Molecular antimicrobial susceptibility testing in sepsis.
Ignacio Martín-LoechesJoão Gonçalves PereiraTee Keat TeohGavin BarlowLaurent DortetEnitan D CarrolUlrike OlgemöllerSara E BoydJulien TextorisPublished in: Future microbiology (2024)
Rapidly detecting and identifying pathogens is crucial for appropriate antimicrobial therapy in patients with sepsis. Conventional diagnostic methods have been a great asset to medicine, though they are time consuming and labor intensive. This work will enable healthcare professionals to understand the bacterial community better and enhance their diagnostic capacity by using novel molecular methods that make obtaining quicker, more precise results possible. The authors discuss and critically assess the merits and drawbacks of molecular testing and the added value of these tests, including the shift turnaround time, the implication for clinicians' decisions, gaps in knowledge, future research directions and novel insights or innovations. The field of antimicrobial molecular testing has seen several novel insights and innovations to improve the diagnosis and management of infectious diseases.